Minot Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$2.91M Sell
55,554
-699
-1% -$35.6K 0.75% 41
2022
Q1
$2.91M Sell
56,253
-800
-1% -$41.5K 0.63% 45
2021
Q4
$3.37M Sell
57,053
-115
-0.2% -$5.7K 0.65% 48
2021
Q3
$2.46M Buy
57,168
+5,510
+11% +$244K 0.53% 53
2021
Q2
$2.05M Buy
51,658
+6,116
+13% +$238K 0.45% 60
2021
Q1
$1.65M Sell
45,542
-25,937
-36% -$921K 0.42% 65
2020
Q4
$2.63M Buy
71,479
+4,101
+6% +$150K 0.79% 47
2020
Q3
$2.35M Buy
67,378
+46,061
+216% +$1.61M 0.88% 48
2020
Q2
$661K Buy
21,317
+3,425
+19% +$116K 0.33% 74
2020
Q1
$554K Buy
17,892
+1,489
+9% +$50.7K 0.4% 67
2019
Q4
$625K Buy
+16,403
New +$584K 0.28% 80

Other funds holding PFE

Minot Wealth Management's PFE Position: Q2 2022 in Review

Minot Wealth Management reduced its Pfizer (PFE) stake by 1.2% in Q2 2022, selling an estimated $35.6K and leaving 55,554 shares worth $2.91M. The position accounts for 0.75% of the portfolio, ranked #41.

Minot Wealth Management first reported a position in PFE in Q4 2019 and has held it in 11 quarters since. The position peaked at $3.37M in Q4 2021. 3,158 funds tracked by Wall St. Rank hold PFE as of Q2 2022.

  • Minot Wealth Management held 55,554 shares of Pfizer worth $2.91M as of Q2 2022.
  • Minot Wealth Management sold 699 Pfizer shares in Q2 2022, an estimated $35.6K.
  • Pfizer made up 0.75% of Minot Wealth Management's portfolio in Q2 2022, its #41 holding.
  • Minot Wealth Management first reported a position in Pfizer in Q4 2019 and has held it in 11 quarters since.
  • Minot Wealth Management's Pfizer position peaked at $3.37M in Q4 2021.
  • 3,158 funds tracked by Wall St. Rank held Pfizer as of Q2 2022.

Based on Minot Wealth Management's 13F filing for Q2 2022, filed 12 Jul 2022.